Impact of the CE mark approval on exit opportunities and validation for early stage medical device companies
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2011.
Main Author: | Kothari, Ashish (Ashish Shrikant) |
---|---|
Other Authors: | Myron Spector and Carl Berke. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/65522 |
Similar Items
-
The accelerated approval process in oncology : an examination of the conversion rate of approved therapies to full approval
by: Kim, Jean Jinsun
Published: (2007) -
Evaluation of the medical device approval lag between the United States and the European Union
by: Dhavale, Todd V
Published: (2012) -
Trends in U.S. regulatory approvals of the biopharmaceutical therapeutic entities
by: Graham, James B., 1976-
Published: (2006) -
Assessing decision inputs in drug development between small, early stage companies and big pharma : is there is a difference?
by: Rippy, Daniel S. (Daniel Spensley)
Published: (2008) -
Medication concepts, records, and lists in electronic medical record systems
by: Chang, Jaime
Published: (2007)